Driehaus Capital Management LLC Mirati Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

$10.2 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $117,479 - $266,130	-3,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $13.7 Million - $27.2 Million	-180,446 Reduced 98.36%	3,000 $247,000
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $4.57 Million - $6.59 Million	34,619 Added 23.26%	183,446 $26.9 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $11.3 Million - $15.2 Million	85,736 Added 135.89%	148,827 $26.3 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $4.16 Million - $5.19 Million	-28,890 Reduced 31.41%	63,091 $10.2 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $1.72 Million - $2.4 Million	-10,836 Reduced 10.54%	91,981 $15.8 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $883,010 - $1.31 Million	-5,449 Reduced 5.03%	102,817 $22.6 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $584,195 - $862,778	5,158 Added 5.0%	108,266 $18 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $97,429 - $162,887	1,353 Added 1.33%	103,108 $11.8 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $247,719 - $412,545	-3,550 Reduced 3.37%	101,755 $7.82 Million
Q4 2019 Feb 12, 2020	SELL	$70.76 - $128.86 $6.14 Million - $11.2 Million	-86,712 Reduced 45.16%	105,305 $13.6 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $6.65 Million - $9.36 Million	-85,379 Reduced 30.78%	192,017 $15 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $4.98 Million - $8.76 Million	83,645 Added 43.17%	277,396 $28.6 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $1.53 Million - $2.77 Million	-35,024 Reduced 15.31%	193,751 $14.2 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $5.16 Million - $7.65 Million	-161,202 Reduced 41.34%	228,775 $9.71 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $2.43 Million - $3.23 Million	-51,493 Reduced 11.66%	389,977 $18.4 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $11.5 Million - $23.1 Million	441,470 New	441,470 $21.8 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account